Association Between Apoliprotein E Gene Polymorphism and Hypercholesterolemic Phenotype in Maracaibo, Zulia State, Venezuela

被引:9
作者
Arraiz, Nailet [1 ]
Bermudez, Valmore [1 ]
Prieto, Carem [1 ]
Patricia Sanchez, Maria [1 ]
Escalona, Carolina [1 ]
Sanz, Eileen [1 ]
Rondon, Netxibeth [1 ]
Reyes, Francia [1 ]
Velasco, Manuel [2 ]
机构
[1] Univ Zulia, Endocrine & Metab Dis Res Ctr, Maracaibo 4004, Zulia State, Venezuela
[2] Cent Univ Venezuela, Vargas Med Sch, Clin Pharmacol Unit, Caracas, Venezuela
关键词
hypercholesterolemia; ApoE; polymorphisms; cardiovascular disease; lipids profile; APOLIPOPROTEIN-E POLYMORPHISM; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; E GENOTYPE; INTERINDIVIDUAL VARIATION; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; LIPID PROFILE; RISK; POPULATIONS;
D O I
10.1097/MJT.0b013e3181c1235d
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Apoliprotein (Apo) E gene polymorphisms have been associated with high plasma lipids levels and cardiovascular disease. The aim of this study was to determine allelic and genotypic frequencies and to evaluate the associations of polymorphisms with hypercholesterolemic phenotypes in a patient population in Maracaibo, Zulia State. Two hundred and twenty- one patients with ages between 9 and 78 years old attending the Endocrine- Metabolic Center at the University of Zulia, Zulia, Venezuela, were recruited. The lipid profile was determined by enzymatic methods. ApoE polymorphisms were determined by polymerase chain reaction- restriction fragment length polymorphism. One hundred and thirty- three dyslipidemic and 88 patients with normal lipids profile were evaluated. The higher proportion of patients corresponded to hypercholesterolemia isolated (46.61%), followed by hypercholesterolemia combined with hypertriglyceridemia and low levels of high- density lipoprotein (21.8%). ApoE epsilon 3 allele was the most frequent in the evaluated population (0.80), both in the control group (0.78) and in the dyslipidemic group (0.82), followed by the epsilon 4 allele (0.12) for both groups and the epsilon 2 allele with values of 0.10 and 0.06, for control and dyslipidemic group, respectively. The epsilon 3 epsilon 3 and epsilon 3 epsilon 4 genotypes were the most frequent in the population, with values of 62.89% and 22.17%, respectively. The genotype frequencies were 57.95% and 66.17% for epsilon 3 epsilon 3; 23.86% and 21.05% for epsilon 3 epsilon 4 in nondyslipide ' micos and dyslipidemic patient groups, respectively. The epsilon 4 epsilon 4 genotype was observed only in hypercholesterolemic patients. The homozygote epsilon 2 epsilon 2 and heterozygote epsilon 2 epsilon 3 genotypes were more frequent at the normal lipids profile group, consistent with diverse reports that indicate the association of the epsilon 4 allele with elevated cholesterol levels and low cholesterol levels when the epsilon 2 allele is present. ApoE polymorphism seems to be associated with variance in serum lipids levels in the population evaluated.
引用
收藏
页码:330 / 336
页数:7
相关论文
共 35 条
[1]   The joins impact of family history of myocardial infarction and other risk factors on 12-year coronary heart disease mortality [J].
Boer, JMA ;
Feskens, EJM ;
Verschuren, WMM ;
Seidell, JC ;
Kromhout, D .
EPIDEMIOLOGY, 1999, 10 (06) :767-770
[2]   Apolipoprotein E genotype and plasma levels in coronary artery disease. A case-control study in the Italian population [J].
Corbo, RM ;
Vilardo, T ;
Ruggeri, M ;
Gemma, AT ;
Scacchi, R .
CLINICAL BIOCHEMISTRY, 1999, 32 (03) :217-222
[3]   Apolipoprotein E (APOE) allele distribution in the world.: Is APOE*4 a 'thrifty' allele? [J].
Corbo, RM ;
Scacchi, R .
ANNALS OF HUMAN GENETICS, 1999, 63 :301-310
[4]   Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages [J].
Cullen, P ;
Cignarella, A ;
Brennhausen, B ;
Mohr, S ;
Assmann, G ;
von Eckardstein, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1670-1677
[5]  
CUMMING AM, 1984, CLIN GENET, V25, P310
[6]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[7]   GENETIC-HETEROGENEITY OF APOLIPOPROTEIN-E AND ITS INFLUENCE ON PLASMA-LIPID AND LIPOPROTEIN LEVELS [J].
DEKNIJFF, P ;
VANDENMAAGDENBERG, AMJM ;
FRANTS, RR ;
HAVEKES, LM .
HUMAN MUTATION, 1994, 4 (03) :178-194
[8]   Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project [J].
Dobson, AJ ;
Evans, A ;
Ferrario, M ;
Kuulasmaa, KA ;
Moltchanov, VA ;
Sans, S ;
Tunstall-Pedoe, H ;
Tuomilehto, JO ;
Wedel, H ;
Yarnell, J .
ANNALS OF MEDICINE, 1998, 30 (02) :199-205
[9]   Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review [J].
Eichner, JE ;
Dunn, ST ;
Perveen, G ;
Thompson, DM ;
Stewart, KE ;
Stroehla, BC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (06) :487-495
[10]   GENOTYPING AND SEQUENCE-ANALYSIS OF APOLIPOPROTEIN-E ISOFORMS [J].
EMI, M ;
WU, LL ;
ROBERTSON, MA ;
MYERS, RL ;
HEGELE, RA ;
WILLIAMS, RR ;
WHITE, R ;
LALOUEL, JM .
GENOMICS, 1988, 3 (04) :373-379